Sirolimus treatment for intractable vascular anomalies ( <scp>SIVA</scp> ): An open‐label, single‐arm, multicenter, prospective trial
Sirolimus may reduce VA tissue volume and potentially improve symptoms and activities of daily living in patients with VAs.
Authors
- Akihiro Fujino (ORCID: https://orcid.org/0000-0003-2987-5081)
- Kyoichi Deie (ORCID: https://orcid.org/0000-0003-0446-047X)
- Michio Ozeki (ORCID: https://orcid.org/0009-0003-0224-4201)
- Junkichi Takemoto
- Takanobu Maekawa (ORCID: https://orcid.org/0000-0001-8488-4752)
- Akihiro Umezawa (ORCID: https://orcid.org/0000-0002-0485-6653)
- Mikiko Miyasaka
- Shiho Yasue (ORCID: https://orcid.org/0000-0001-6272-5638)
- Shigehisa Fumino (ORCID: https://orcid.org/0000-0002-8886-2515)
- Motoi Kato (ORCID: https://orcid.org/0000-0002-2996-7771)
- Hiroya Hashimoto (ORCID: https://orcid.org/0000-0003-1865-4953)
- Naonori Kawakubo (ORCID: https://orcid.org/0000-0003-0010-4902)
- Shunsuke Nosaka (ORCID: https://orcid.org/0000-0002-9182-2717)
- Akiko Saito (ORCID: https://orcid.org/0000-0003-3723-8445)
- Ryuta Asada (ORCID: https://orcid.org/0000-0003-2228-1272)
- Tatsuo Kuroda (ORCID: https://orcid.org/0000-0001-7183-2830)
- Shigeru Ueno
- Satoshi Hirakawa (ORCID: https://orcid.org/0000-0003-2510-8985)
- Saori Endo
- Mototoshi Kato
- Tatsuro Tajiri
- Taizo Furukawa
- Kentaro Matsuoka
- Shôji Watanabe
Institutions
- Tokai University (JP)
- Kyushu University (JP)
- Keio University (JP)
- Hamamatsu University School of Medicine (JP)
- Nagoya City University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Saitama Children's Medical Center (JP)
- Okayama University Hospital (JP)
- National Center For Child Health and Development (JP)
- Tokyo Metropolitan Children's Medical Center (JP)
- Nagoya Medical Center (JP)
- Gifu University (JP)
- Kitasato University (JP)
Publication Details
- Journal
- Pediatrics International
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1111/ped.70002
- Citations
- 3
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 6.02
Funders
- Japan Agency for Medical Research and Development